Protokinetix has a total of 32 patents globally, out of which 9 have been granted. Of these 32 patents, more than 81% patents are active. The USA is where Protokinetix has filed the maximum number of patents, followed by Canada and Europe (EPO). Parallelly, the USA seems to be the main focused R&D center of Protokinetix and is also the origin country of the firm.
Protokinetix was founded in the year 2002 by Clarence E. Smith and Michael Guzzetta. The company is a research and development firm that specializes in cell survival solutions.
Do read about some of the most popular patents of Protokinetix which have been covered by us in this article and also you can find Protokinetix patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Protokinetix patent portfolio.
How many patents does Protokinetix have?
Protokinetix has a total of 32 patents globally. These patents belong to 7 unique patent families. Out of 32 patents, 26 patents are active.
How Many Patents did Protokinetix File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Protokinetix Applications Filed | Protokinetix Patents Granted |
| 2022 | 1 | 4 |
| 2021 | 13 | 1 |
| 2020 | 1 | – |
| 2019 | – | – |
| 2018 | 1 | – |
| 2017 | 6 | – |
| 2016 | – | – |
| 2015 | 8 | 1 |
| 2014 | – | – |
| 2013 | – | 1 |
| 2012 | – | – |
| 2011 | – | – |
How many Protokinetix patents are Alive/Dead?
Worldwide Patents
How Many Patents did Protokinetix File in Different Countries?
Countries in which Protokinetix Filed Patents
| Country | Patents |
| United States Of America | 7 |
| Canada | 5 |
| Europe | 4 |
| Korea (South) | 3 |
| China | 3 |
| Australia | 3 |
| India | 1 |
| New Zealand | 1 |
| Hong Kong (S.A.R.) | 1 |
Where are Research Centres of Protokinetix Patents Located?
Most Cited Protokinetix Patent
US20150352155A1 is the most popular patent in the Protokinetix portfolio. It has received 4 citations so far.
List of Protokinetix Patents
| Protokinetix Patents | Title |
| US11096968B2 | Use Of Anti-Aging Glycoprotein For Enhancing Survival Of Neurosensory Precursor Cells |
| US8394362B2 | Gem Difluorinated C-Glycopeptides, Their Preparation And Their Use For The Preservation Of Biological Materials And/Or In Cryosugery |
| US20230142705A1 | Use Of Anti-Aging Glycopeptides For Inhibition Of Immune Rejection Of A Graft |
| US20210330712A1 | Use Of Anti-Aging Glycoprotein For Enhancing Survival Of Neurosensory Precursor Cells |
| US20210023142A1 | Use Of Anti-Aging Glycopeptides To Enhance Beta Cell Health, Survival And Improve Transplant Outcome |
| EP3407876B1 | Use Of Anti-Aging Glycoprotein For Enhancing Survival Of Neurosensory Precursor Cells |
| EP4093422A4 | Use Of Anti-Aging Glycopeptides For Inhibition Of Immune Rejection Of A Graft |
| EP4117705A1 | Use Of Anti-Aging Glycopeptides For Treatment Of Dry Eye Disease, Retinal Degenerative Diseases, Or Occular Inflammation |
| EP3152297A4 | Use Of Anti-Aging Glycopeptides To Enhance Pancreatic Cell Health, Survival And Improve Transplant Outcome |
| CN106661549B | Application Of Anti-Aging Glycopeptide For Enhancing Pancreatic Cell Health, Survival And Improving Transplantation Effect |
| CN115568282A | Use Of Anti-Aging Glycopeptide For Treating Dry Eye Disease, Retinal Degenerative Disease Or Ocular Inflammation |
| CN115427061A | Anti-Aging Glycopeptides For Inhibiting Immune Rejection Of Graft |
| CA2588801C | Gem Difluorinated C-Glycopeptides, Their Preparation And Their Use For The Preservation Of Biological Materials And/Or In Cryosurgery |
| AU2015271608B9 | Use Of Anti-Aging Glycopeptides To Enhance Pancreatic Cell Health, Survival And Improve Transplant Outcome |
| CA3171236A1 | Use Of Anti-Aging Glycopeptides For Treatment Of Dry Eye Disease, Retinal Degenerative Diseases, Or Occular Inflammation |
| CA3165196A1 | Use Of Anti-Aging Glycopeptides For Inhibition Of Immune Rejection Of A Graft |
| CA3011449A1 | Use Of Anti-Aging Glycoprotein For Enhancing Survival Of Neurosensory Precursor Cells |
| CA2950963A1 | Use Of Anti-Aging Glycopeptides To Enhance Beta Cell Health, Survival And Improve Transplant Outcome |
| AU2021233436A1 | Use Of Anti-Aging Glycopeptides For Treatment Of Dry Eye Disease, Retinal Degenerative Diseases, Or Occular Inflammation |
| AU2021211397A1 | Use Of Anti-Aging Glycopeptides For Inhibition Of Immune Rejection Of A Graft |
| KR2411834B1 | Use Of Anti-Aging Glycopeptides To Enhance Pancreatic Cell Health, Survival And Improve Transplant Outcome |
| KR2023019070A | Use Of Anti-Aging Glycopeptides For The Treatment Of Dry Eye Syndrome, Retinal Degenerative Diseases, Or Eye Inflammation |
| KR2022137037A | Use Of Anti-Aging Glycopeptides For Inhibition Of Immune Rejection Of Grafts |
| IN384632B | Use Of Anti Aging Glycopeptides To Enhance Pancreatic Cell Health Survival And Improve Transplant Outcome |
| HK1237814B | Use Of Anti-Aging Glycopeptides To Enhance Pancreatic Cell Health, Survival And Improve Transplant Outcome |
| NZ727749A | Use Of Anti-Aging Glycopeptides To Enhance Beta Cell Health, Survival And Improve Transplant Outcome |
| US20170360844A1 | Use Of Anti-Aging Glycopeptides To Enhance Pancreatic Cell Health Survival And Improve Transplant Outcome |
| US20150352155A1 | Use Of Anti-Aging Glycopeptides To Enhance Pancreatic Cell Health, Survival And Improve Transplant Outcome |
| WO2021179081A1 | Use Of Anti-Aging Glycopeptides For Treatment Of Dry Eye Disease, Retinal Degenerative Diseases, Or Occular Inflammation |
| WO2021146812A1 | Use Of Anti-Aging Glycopeptides For Inhibition Of Immune Rejection Of A Graft |
| WO2017130148A1 | Use Of Anti-Aging Glycoprotein For Enhancing Survival Of Neurosensory Precursor Cells |
| WO2015184544A1 | Use Of Anti-Aging Glycopeptides To Enhance Pancreatic Cell Health, Survival And Improve Transplant Outcome |
What are Protokinetix’s key innovation segments?
What Technologies are Covered by Protokinetix?
The chart below distributes patents filed by Protokinetix